Inventor · disambiguated record
Joseph R. Bertino
Also filed as: BERTINO JOSEPH · BERTINO JOSEPH R · BERTINO JOSEPH ROCCO
21 granted patents·13 pending applications·250 citations·filing 1997–2024
94Inventor score
Files withUNIV RUTGERS12SLOAN KETTERING INST CANCER9PHARMA MAR SAU2BANERJEE DEBRABRATA1BERTINO JOSEPH R1
Top patents by PatentIndex Score
34 records- 0195US6204388B1Synthesis of epothilones, intermediates thereto and analogues thereofSLOAN KETTERING INST CANCER·Filed 1999·Granted Mar 20, 2001·143 cites·9 claims
- 0285US8058061B2Vector encoding human globin gene and use thereof in treatment of hemoglobinopathiesSADELAIN MICHEL·Filed 2009·Granted Nov 15, 2011·4 cites·15 claims
- 0385US6603023B2Synthesis of epothilones, intermediates thereto and analogues thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Aug 5, 2003·12 cites·23 claims
- 0484US7541179B2Vector encoding human globin gene and use thereof in treatment of hemoglobinopathiesSLOAN KETTERING INST CANCER·Filed 2002·Granted Jun 2, 2009·12 cites·24 claims
- 0583US2025011470A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2024·Application pending·0 cites
- 0680US10376597B2Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2017·Granted Aug 13, 2019·1 cites·10 claims
- 0778US9849192B2Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2016·Granted Dec 26, 2017·1 cites·3 claims
- 0877US7381703B2Aplidine for multiple myeloma treatmentDANA FABER CANCER INST INC·Filed 2004·Granted Jun 3, 2008·12 cites·3 claims
- 0975US6965034B2Synthesis of epothilones, intermediates thereto and analogues thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Nov 15, 2005·3 cites·39 claims
- 1075US2024245801A1Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moietiesUNIV RUTGERS·Filed 2023·Application pending·0 cites
- 1173US7576188B2Antitumoral treatmentsPHARMA MAR SAU·Filed 2004·Granted Aug 18, 2009·11 cites·14 claims
- 1272US2019358340A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2019·Application pending·0 cites
- 1371US2021177985A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2021·Application pending·0 cites
- 1470US8822421B2E2F as a target of hormone refractory prostate cancerBERTINO JOSEPH R·Filed 2011·Granted Sep 2, 2014·2 cites·11 claims
- 1567US11752215B2Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moietiesUNIV RUTGERS·Filed 2021·Granted Sep 12, 2023·0 cites·9 claims
- 1667US6642043B1Double mutants of dihydrofolate reductase and methods of using sameSLOAN KETTERING INST CANCER·Filed 1997·Granted Nov 4, 2003·29 cites·12 claims
- 1764US9314497B2E2F as a target of hormone refractory prostate cancerUNIV RUTGERS·Filed 2014·Granted Apr 19, 2016·0 cites·8 claims
- 1864US7514413B2In-vivo energy depleting strategies for killing drug-resistant cancer cellsSLOAN KETTERING INST CANCER·Filed 2003·Granted Apr 7, 2009·1 cites·7 claims
- 1960US7381713B2Treatment of cancer by reduction of intracellular energy and pyrimidinesSIOAN KETTERING INST FOR CANCE·Filed 2002·Granted Jun 3, 2008·2 cites·8 claims
- 2058US2010151004A1Modulation of drug sensitivityUNIV NEW JERSEY MED·Filed 2008·Application pending·0 cites
- 2154US9549993B2Specific delivery of toxins conjugated with antibodies to activate matripaseUNIV RUTGERS·Filed 2013·Granted Jan 24, 2017·0 cites·11 claims
- 2253US2009227490A1Antitumoral TreatmentsPHARMA MAR SAU·Filed 2009·Application pending·0 cites
- 2353US2004053836A1Method for modulating the production of a selected protein in vivoFiled 2003·Application pending·0 cites
- 2452US2011020291A1Use of stem cells for wound healingBANERJEE DEBRABRATA·Filed 2008·Application pending·0 cites
- 2551US9682094B2Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesUNIV RUTGERS·Filed 2015·Granted Jun 20, 2017·0 cites·13 claims
- 2650US11604133B2Use of multi-frequency impedance cytometry in conjunction with machine learning for classification of biological particlesUNIV RUTGERS·Filed 2020·Granted Mar 14, 2023·0 cites·15 claims
- 2749US2019151464A1Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moietiesUNIV RUTGERS·Filed 2017·Application pending·0 cites
- 2848US6887467B1Double mutants of dihydrofolate reductase and methods of using sameSLOAN KETTERING INST CANCER·Filed 2003·Granted May 3, 2005·0 cites·8 claims
- 2948US6416987B1Mutants of thymidylate synthase and uses thereofSLOAN KETTERING INST CANCER·Filed 1998·Granted Jul 9, 2002·10 cites·11 claims
- 3048US2006003936A1Method for modulating the production of a selected protein in vivoMAYER-KUCKUK PHILIPP·Filed 2005·Application pending·0 cites
- 3148US2010240595A1Improved Antitumoral TreatmentsPHARMA MAR SA·Filed 2008·Application pending·0 cites
- 3248US2003069277A1Synthesis of epothilones, intermediates thereto and analogues thereofFiled 2002·Application pending·0 cites
- 3342US6355639B1Reverse prenyl compounds as immunosuppressantsSLOAN KETTERING INST CANCER·Filed 1998·Granted Mar 12, 2002·7 cites·14 claims
- 3438US2012294800A1Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesLIN SIANG-YO·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →